The District of Columbia held its Democratic primary yesterday, and the results are mostly good news for supporters of marijuana policy reform. Below are the (unofficial) results, along with the grade the council candidates received in MPP’s voter guide:

Ward 2: Jack Evans (A+) won (unopposed)

Ward 4: Incumbent Brandon Todd (F) beat challenger Leon Andrews (A), 49% to 41%

Ward 7: Challenger Vincent Gray (C+) beat incumbent Yvette Alexander (D), 60% to 33%

Ward 8: Challenger Trayon White (C+) beat incumbent LaRuby May (D), 51% to 42%

In the at-large race, all the candidates received an A or A+ from MPP. Challenger Robert White beat incumbent Vincent Orange 40% to 37%.

As the general election on November 8 approaches, MPP plans to update our voter guide to keep you informed on all the candidates’ positions, so stay tuned!

MPP has formally endorsed Libertarian Party nominee and former New Mexico Gov. Gary Johnson in the race for president. Johnson is one of two candidates who received an "A+" grade in MPP's presidential candidate report card.

Below is a statement from our Executive Director, Rob Kampia, that contextualizes MPP's endorsement.

"MPP is a single-issue organization, and our mission is simple: 'Regulate marijuana similarly to alcohol in the United States.' We don't take a position -- and we therefore don't take into account a candidate's position -- on other issues, such as abortion, guns, gay rights, Iraq, taxes, or Social Security. We also don't work in Canada or Portugal.

"Of the three presidential candidates who will appear on the ballot in all 50 states and D.C., Gary Johnson clearly has the best position on marijuana policy. When he first advocated for legalization in 1999, he was the highest-ranking public official in the U.S. to do so -- as the sitting Republican governor of New Mexico, no less.

"Shortly after he left office, Johnson and I drove around New England lobbying the governors of VT and RI, the speaker of the NH House, and staffers in the NY governor's office. Johnson is a forceful advocate for legalization and is still one of MPP's strongest allies.

"Legalization has been Johnson's number-one issue for 17 years. MPP's endorsement of Johnson was an easy call; the more difficult question is whether MPP should support a candidate who's good on medical marijuana but bad on legalization, when the candidate is facing an opponent who's bad on everything.

"It's fine if voters prefer to consider a candidate's marijuana position in the context of a dozen other positions, but that's not MPP's mission. We're narrowly focused on marijuana policy and are happy to work alongside anyone who shares our mission, whether they're Socialists, Republicans, or otherwise."

On Wednesday, Ohio Gov. John Kasich signed HB 523 into law, bringing the promise of relief to thousands of seriously ill patients in the Buckeye State. His action also marks an important milestone in the medical marijuana movement: Ohio’s new law means that now half the states in the U.S. have workable medical marijuana laws for their citizens.

While this is an important step, more work lies ahead. Several agencies will administer the program, including the Department of Commerce, the State Board of Pharmacy, and the State Medical Board of Ohio. These agencies are expected to start developing rules in the coming months as Ohio begins the process of creating a workable system. Please join us in our efforts to ensure the system is fair and delivers on the promises lawmakers made to create a compassionate program.

We are very grateful to everyone who worked so hard to bring protections to seriously ill patients. Were it not for the donors, volunteers, and signature gatherers who gave so much to the Ohioans for Medical Marijuana amendment, this day would not have come.  As the process moves forward, we will use that amendment as a road map as we work to implement and improve this law.

A study released this week from the Journal of the American Medical Association Psychiatry suggests that the harms associated with long-term marijuana use are much less than previously claimed.

Time reports:

Even after years of heavy use, marijuana doesn’t seem to have much of an impact on the physical health of the body.

So finds a recent study published in JAMA Psychiatry, which analyzed data from a group of 1,037 New Zealanders followed from their birth until age 38. The researchers, led by Madeline Meier of Arizona State University, looked at whether cannabis use from age 18 to 38 was linked to several aspects of physical health, which were measured at several points throughout the years of the study through lab tests and self-reports.

The only bad effects pot seemed to have were on the teeth. At age 38, people who used cannabis had worse periodontal health than their peers, and nothing else appeared to be affected. By contrast, tobacco use was connected to all the expected declines: worse lung function, more inflammation and compromised metabolic health. Of course, the results come with a caveat; it’s possible that negative health effects of cannabis could show themselves after the age of 38.

Even more surprisingly, the researchers found that cannabis use over time was linked to a lower BMI, smaller waist circumference and better HDL cholesterol, suggesting that cannabis may be involved in metabolism. But it’s unlikely that this would have a major effect, the study authors note, since pot wasn’t linked to reduced risk of metabolic syndrome.

“There are definitely health risks associated with heavy marijuana use, but there just aren’t as many as we previously thought,” says Dr. Kevin Hill, a marijuana addiction expert and assistant professor of psychiatry at Harvard Medical School, whose new commentary on the study is published Tuesday in JAMA.

Compared to the increasingly disproven claims made by prohibitionists about the severe negative health outcomes of marijuana consumption, bad teeth isn't all that bad. It is certainly not a sufficient reason to continue arresting adults for a substance that is objectively safer than alcohol.

The Vermont medical marijuana program took an important step forward today when Gov. Peter Shumlin signed S. 14, a bill that will make it possible for more patients to qualify for the medical marijuana program.

[caption id="attachment_9468" align="alignright" width="250"] Gov. Peter Shumlin. VTD/Josh Larkin[/caption]

"At a time when opiate addiction is ravaging our state and drug companies continue to urge our doctors to pass out painkillers like candy, we need to find a more practical solution to pain management," Shumlin said in a statement.

Specifically, the bill reduces the threshold for a pain diagnosis from "severe pain" to "chronic pain." It also adds glaucoma as a qualifying condition, and it reduces the required provider-patient relationship from six months to three months. A summary of these changes and others made by S. 14 is available here.

The West Virginia Legislature failed to reform its marijuana policies in the 2015-2016 legislative session, primarily because House Speaker Tim Armstead continues to oppose even the most modest, incremental reforms. Fortunately, now that a special session has been called, five delegates have decided this is an opportunity to raise the issue of marijuana legalization. Del. Mike Pushkin (D-Charleston) and a bipartisan group of four co-sponsors have introduced HB 114, which would make marijuana legal on a limited basis in West Virginia.

The Charleston Gazette-Mail published an editorial praising these legislators' efforts, calling legalization an "excellent idea." The Gazette-Mail noted that the bill "has no chance" of passing in the special session, but it still presents an important opportunity to raise the issue with elected officials.

If you are a West Virginia resident, please take a moment to contact your delegates and senators today and urge them to consider the benefits of ending marijuana prohibition.

On Tuesday, the Illinois Senate approved a key bill that would change the sunset date on the state’s medical cannabis program from January 1, 2018 to July 1, 2020. The House approved the bill on Monday. The final votes on SB 10 capped off a whirlwind effort by lawmakers in the closing days of the 2016 session.

[caption id="attachment_9824" align="alignright" width="175"] Rep. Lou Lang[/caption]

In addition to extending the program by two and a half years, SB 10 would allow patients with post-traumatic stress disorder or a terminal illness to qualify for medical cannabis. It would also allow doctors to simply state that a patient has a qualifying condition, rather than recommend cannabis. Finally, SB 10 would change the process for petitioning to add medical conditions and modify the composition of the advisory board.

[caption id="attachment_9825" align="alignleft" width="165"] Sen. Jim Durkin[/caption]

The vote was over a year in the making, and while the measure passed both chambers by a wide margin, its success was far from certain. Special thanks go to Deputy House Majority Leader Lou Lang and House Minority Leader Jim Durkin, who both worked hard to gain critical support from lawmakers and Gov. Bruce Rauner. Thanks also go to the many supporters and patients who reached out to lawmakers.

Once received, Gov. Rauner will have 60 days to sign the bill into law. SB 10 is available here.

On May 25, 2016, the Ohio General Assembly passed House Bill 523, a limited but workable medical marijuana bill that would allow seriously ill patients to use and purchase cannabis. This bill is now heading to the desk of Gov. John Kasich, who could sign the bill, veto it, or allow it to become law without his signature. If you are an Ohio resident, please urge him to sign this compassionate bill into law.

This legislation was a direct response to an initiative MPP funded and sought to qualify for the November 2016 ballot. The medical marijuana program established by the bill does not provide for smoking, nor does it allow home cultivation. However, the bill as passed was greatly improved upon from its original version. Unlike some legislatively-approved bills, it includes chronic and severe pain as a qualifying condition.

Due to the legislature passing a workable bill, MPP has suspended its signature collection campaign. We are optimistic that seriously ill patients in Ohio will soon have access to this important treatment option upon their doctors’ recommendations. In conjunction with Ohioans for Medical Marijuana, we plan to continue advocacy efforts to ensure that the State of Ohio lives up to the promises contained in HB 523, while also working to better the program using the ballot initiative proposal as a roadmap for these improvements.

From the OMM press release:

Late Friday evening, after considerable discussion, the decision was made to suspend our drive to place an issue on the November 2016 Ohio ballot.

We make this decision with a heavy heart as we will surely disappoint our many volunteers, supporters and patient-advocates who invested considerable time and effort in our movement.

It had become increasingly clear following the state legislature’s passage of a medical marijuana law on Wednesday that our ballot issue campaign had arrived at a critical juncture.

With several hundred thousand signatures collected thus far, one option for our movement would have been to continue to pour our resources into obtaining the additional signatures needed to put the issue before voters.

But the reality is that raising funds for medical marijuana policy changes is incredibly difficult, especially given the improvements made to the proposed program by the Ohio General Assembly and the fact that the Governor is expected to sign the bill.

As we said following Wednesday’s vote, the legislature’s action on medical marijuana was a step forward, and thanks to the intense advocacy efforts of patients and their families, activists and our team the bill was vastly improved before passage. Removed from the bill was much of the red tape and onerous regulations that would have severely limited patient access, and added was a very important provision granting an affirmative defense to qualifying patients beginning this fall. Also stripped from the bill were troubling provisions raising the threshold for pain.

To be sure, there are shortcomings to the legislature’s measure. There are a number of qualifying conditions which should have been included, and we firmly believe that patients should have the right to smoke and grow their own medical marijuana.

But, all in all, it is a moderately good piece of legislation passed by lawmakers who were pushed hard by the patient community.

We plan on continuing forward as an advocacy effort to ensure that the State of Ohio lives up to the promises contained in HB 523, but also working to better the program utilizing our amendment as a roadmap for those improvements.

But the reality is for us, this campaign to put our issue on the 2016 ballot ends today. To everyone who joined us on this effort, especially those patients and their families who will benefit from Ohio’s new medical marijuana program, we owe you a debt of gratitude.

The Louisiana Legislature continues to repeat its mistakes. For nearly 40 years, flawed legislative drafting has prevented the establishment of a workable medical marijuana program. Yesterday, the House took another step forward by passing S.B. 180, but it failed to fix a key omission.

Last week, Gov. John Bel Edwards signed into law S.B. 271, legislation intended to fix a poison pill so Louisiana can establish a medical marijuana program (you can read about it here). However, that law did not amend the criminal statutes, meaning the program would provide medical marijuana to seriously ill patients but allow for their prosecution.

S.B. 180, Sen. Frank Mills’ companion bill, seeks to close this loophole and does so for patients and caregivers. Unfortunately, the House did not even consider amending the bill to also shield growers, pharmacies, or their workers from criminal liability. While a court could find legal protections implicit for licensees, the omission could jeopardize the entire program.

S.B. 180 is now before the Senate for a concurrence.

When this session ends, Louisiana will be significantly closer to offering relief to seriously ill patients. The regulatory and licensing process will take many months, and final fixes can be made next session if they are needed. Meanwhile, the state can move to lay the structure for the program.

[caption id="attachment_9815" align="alignright" width="200"] Gov. Dannel Malloy[/caption]

Earlier this month, Gov. Dannel Malloy signed HB 5450, which will make changes to Connecticut’s medical marijuana program including to allow certain patients who are under 18 to access medical cannabis. The bill previously passed the House 129 to 3 and the Senate 23 to 1.

To participate in Connecticut's medical marijuana program, minors will have to have been diagnosed with terminal illness, an irreversible spinal cord injury, cerebral palsy, cystic fibrosis, or severe or intractable epilepsy. In addition, they must have a written certification from two doctors — a primary care provider and a specialist. Finally, a parent or guardian must also submit a written statement of consent and attest that they will serve as the minor patient’s primary caregiver.

Connecticut first enacted medical marijuana legislation in 2012, but the law did not allow access for minor patients, many of whom would benefit greatly from access to this safe and effective treatment. Of the 24 states that have effective medical marijuana programs, Connecticut is the last state to exclude younger patients.

The new law will also extend legal protections to nurses who administer medical marijuana to patients in hospitals, and creates a research program. It goes into effect on October 1.